PLTR vs PRAX · P/E 584, rev $4.48B vs rev $8.6M
Palantir Technologies Inc. Class A Common Stock (PLTR) versus Praxis Precision Medicines Inc (PRAX) — a side-by-side from cached financials, not a winner call.
Palantir Technologies Inc. Class A Common Stock (PLTR) is a software - infrastructure company listed on US. It is led by Alex Karp.
Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.
Latest reported PLTR revenue for 2025-12-31 was $4.48B. Net income was $1.63B. Revenue was up 56.2% from 2024-12-31 to 2025-12-31. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
Latest reported PRAX revenue for 2024-12-31 was $8.6M. Net income was -$58.7M. Revenue was up 249.5% from 2023-12-31 to 2024-12-31. PRAX currently screens at market cap $7.38B.
PLTR currently screens at market cap $317.08B and trailing P/E 584.2. PRAX currently screens at market cap $7.38B.
Not investment advice. Open the PLTR and PRAX stock pages for the full models.
Not investment advice.